If a BRCA1 or BRCA2 mutation is present, affected individuals develop breast cancer about 20 years earlier than women with sporadic cancer, with a cumulative lifetime risk of 60% on average for developing breast cancer and 16–55% for developing ovarian cancer [7]. This evidence concerns the gene BRCA1 and breast cancer.